On Tuesday, Shares of RetailMeNot, Inc. (NASDAQ:SALE), gained 16.73% to $20.09.
RetailMeNot, declared its financial results for the first quarter ended March 31, 2015.
First Quarter Financial Results Highlights and Key Operating Metrics
- Total net revenues declined 1% to $60.4 million.
- Mobile online transaction net revenues raised 137% to $5.6 million, representing 9% of total net revenues.
- Advertising + in-store net revenues raised 100% to $7.7 million, representing 13% of total net revenues.
- Desktop online transaction net revenues, which comprises desktop and tablet, declined 14%, to $47.1 million, representing 78% of total net revenues.
- Net revenues from international markets were flat, totaling $13.7 million, representing 23% of total net revenues.
- GAAP net income was $4.1 million, reflecting a decrease of 33%, contrast to $6.1 million.
- Non-GAAP net income was $10.8 million, reflecting a decrease of 15%, contrast to $12.6 million.
- EPS was $0.07 per share, based on 55.0 million fully-diluted, weighted-average shares outstanding.
- Non-GAAP EPS was $0.20 per share, based on 55.0 million fully-diluted, weighted-average shares outstanding.
- Adjusted EBITDA was $18.7 million, down 13% and representing 31% of total net revenues.
- Total visits grew 16% to 179.9 million.
- Monthly mobile unique visitors grew 55% totaling 18.4 million.
RetailMeNot, Inc. operates a digital coupon marketplace. Its marketplace connects consumers with retailers and brands. The company owns and operates digital coupon Websites, counting RetailMeNot.com in the United States.
At the end of Tuesday’s trade, Shares of ABIOMED, Inc. (NASDAQ:ABMD), jumped 15.86% to $75.47, hitting its highest level.
ABIOMED, stated fiscal fourth quarter 2015 revenue of $67.6 million, up 34% contrast to revenue of $50.4 million in the same period of fiscal 2014, and a fiscal fourth quarter 2015 GAAP net income of $98.9 million, or $2.24 per diluted share, contrast to $3.6 million, or $0.09 per diluted share, in the preceding year period.
Fiscal fourth quarter GAAP income from operations totaled $12.4 million, up 235% contrast to $3.7 million in the preceding year. GAAP net income comprised of an income tax benefit of $86.5 million largely due to the release of the valuation allowance on most of Abiomed’s deferred tax assets. The release of the valuation allowance is a onetime accounting adjustment with the offset recorded on the balance sheet as short and long term deferred tax assets based on the Company’s estimates of sustainable profitability.
For fiscal year 2015, total revenue was $230.3 million, up 25% contrast to revenue of $183.6 million in fiscal year 2014. GAAP net income was $113.7 million or $2.65 per diluted share contrast with $7.4 million or $0.18 per diluted share in fiscal year 2014.
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products comprise of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology.
Emerald Oil, Inc. (NYSEMKT:EOX), ended its last trade with 15.38% gain, and closed at $0.75.
Emerald Oil, declared financial and operational results for the quarter ended March 31, 2015.
Highlights
- First quarter production of 424,318 BOE raised 88% as contrast to 225,905 BOE in the first quarter of 2014. Daily production averaged 4,715 BOEPD, 14% above the midpoint and 10% above the high end of Emerald’s first quarter 2015 guidance range;
- Accomplished semi-annual borrowing base redetermination resulting in an elected commitment of $200 million;
- Semi-annual redetermination comprises an expanded total debt to EBITDA covenant of 5.0x and a new senior secured debt to EBITDA covenant of 2.5x;
- Hedging update: Recently initiated 2015 crude oil floors at $55.00 for 4,000 Bbl/d and 2016 crude oil floors at $60.00 for 3,000 Bbl/d while retaining all upside to future crude oil price enhances;
- First quarter oil and gas revenue of $14.5 million;
- First quarter Adjusted EBITDA of $7.4 million;
- First quarter Adjusted net income (loss) attributable to common stockholders of $(6.4) million or $(0.07) per share.
Emerald Oil, Inc. operates as an independent oil and natural gas exploration and production company in the United States. The company designs, drills, and operates oil and natural gas wells. It primarily focuses on acquiring acreage and developing oil and natural gas wells in the Williston Basin located in North Dakota and Montana.
Finally, Clean Diesel Technologies Inc. (NASDAQ:CDTI), closed at $2.09, with 12.97% gain.
Clean Diesel Technologies, declared it will report First Quarter 2015 Financial Results on Tuesday, May 12, 2015 preceding to opening of the market. CDTi will hold a conference call that same day at 8:00 a.m. PT (11:00 a.m. ET) to talk about the results with the investment community.
Clean Diesel Technologies, Inc. manufactures and distributes light duty vehicle catalysts and heavy duty diesel emissions control systems and products to automakers, distributors, integrators, and retrofitters in the United States, Canada, Sweden, and the United Kingdom. It operates through two divisions, Catalyst and Heavy Duty Diesel Systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
